1029 | 16:00 | FRO: The effect of AMA0428, a novel rock inhibitor, in a model of wet age-related macular degeneration | HOLLANDERS K, VAN BERGEN T, VANDEWALLE E, CASTERMANS K, KINDT N, MOONS L, STALMANS I | |||||
1030 | 16:09 | FRO: Subconjunctival bevacizumab enhances the antifibrotic effect of MMC and allows to reduce its exposure time to improve safety | VAN BERGEN T, VANDEWALLE E, MOONS L, STALMANS I | |||||
  | ||||||||
1032 | 16:27 | FRO: Rho Kinase Inhibitor AMA0526 Improves Surgical Outcome in a Rabbit Model of Glaucoma Filtration Surgery | VAN DE VELDE S, VAN BERGEN T, VANDEWALLE E, CASTERMANS K, KINDT N, MOONS L, STALMANS I | |||||
1033 | 16:36 | FRO: Surprising immunohistochemistry of the vitreolenticular interface in developmental cataracts | VAN LOOVEREN J, VAN GERWEN V, TASSIGNON MJ | |||||
1034 | 16:45 | FRO: Identification of the gene signature of retinal endothelial cells during classical experimental autoimmune uveitis, Th1- and Th17-dependent uveitis | LIPSKI D., DEWISPELAERE R., FOUCART V., CASPERS L., BRUYNS C., WILLERMAIN F. |